journal article·2025-10-15

A Synthetic Liposome Nanoparticle Vaccine Platform for Broad-Spectrum Vaccine Design

Mo Zhang, Zihan Gao, Sheng Feng, Xun Wang, Huaiyu Wang, Chumeng Yang, Xiaolei Lin, Zhiqiang Xu, Nan Zhang, Yiyang Li, Haochen Tian, Ningyi Jin, Bin Yu, Pengfei Wang, Chang Li, Xianghui Yu

Nano Letters· Volume 25· Issue 41
Publisher page

Abstract

Emerging viruses such as SARS-CoV-2 and HIV-1 pose major challenges for traditional vaccines due to their rapid mutation and immune evasion. Here, we present a modular liposomal nanoparticle (LNP) vaccine platform integrating trimeric immunogens and synergistic adjuvants to induce broad and durable immunity. Using a self-assembled SARS-CoV-2 RBD trimer (RM) based on MTQ and Ni 2+ /His-tag coupling, antigens were directionally displayed on LNPs coloaded with QS-21, MPLA, and R848 adjuvants. This RM-LNP formulation enhanced antigen stability, lymph node targeting, and germinal center responses, eliciting high titers of broadly neutralizing antibodies and strong T and memory B cell immunity. The RM-LNP vaccine conferred potent neutralization against Omicron subvariants and protected hACE2 mice from Delta, BA.5, and XBB infection. Extension to HIV-1 vaccine design also demonstrated significant and broad neutralization against Tier 2 strains. This study offers a versatile nanovaccine strategy for combating highly mutable viruses.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: SARS-CoV-2 and COVID-19 Research · Immunotherapy and Immune Responses · vaccines and immunoinformatics approaches

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

National Engineering Laboratory for AIDS Vaccine, School of Life Sciences

Jilin University

Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, State Key Laboratory of Pathogen and Biosecurity, Key Laboratory of Jilin Province for Zoonosis Prevention and Control, Research Unit of Key Laboratory of Jilin Province for Zoonosis Prevention and Control

Chinese Academy of Medical Sciences

Shanghai Pudong Hospital, Fudan University Pudong Medical Center, School of Life Sciences, Shanghai Institute of Infectious Disease and Biosecurity

Fudan University

Key Laboratory for Molecular Enzymology and Engineering, the Ministry of Education, School of Life Sciences

Funding

National Key Research and Development Program of China · Program for Jilin University Science and Technology Innovative Research Team · CAMS Innovation Fund for Medical Sciences · “Medicine + X” Interdisciplinary Innovation Team of Norman Bethune Health Science Center of Jilin University

References (23)

Show source-provided references
1. 10.1016/S0140-6736(21)02758-610.1016/S0140-6736(21)02758-6 ↗
2. 10.1126/science.107044110.1126/science.1070441 ↗
3. 10.1056/NEJMc08637310.1056/NEJMc086373 ↗
4. 10.1056/NEJMc220690010.1056/NEJMc2206900 ↗
5. 10.1136/bmjmed-2021-00004010.1136/bmjmed-2021-000040 ↗
6. 10.1038/s41586-020-2012-710.1038/s41586-020-2012-7 ↗
7. 10.1016/j.cell.2021.01.03510.1016/j.cell.2021.01.035 ↗
8. 10.1038/s41577-020-00480-010.1038/s41577-020-00480-0 ↗
9. 10.1007/978-1-4939-3389-1_2610.1007/978-1-4939-3389-1_26 ↗
10. 10.1126/science.aac422310.1126/science.aac4223 ↗
11. 10.1038/nri286810.1038/nri2868 ↗
12. 10.1088/1478-3975/4/3/00410.1088/1478-3975/4/3/004 ↗
13. 10.1021/acsomega.2c0426610.1021/acsomega.2c04266 ↗
14. 10.1038/s41467-020-20653-810.1038/s41467-020-20653-8 ↗
15. 10.1016/j.cell.2021.09.01510.1016/j.cell.2021.09.015 ↗
16. 10.1038/s41467-022-30222-w10.1038/s41467-022-30222-w ↗
17. 10.1016/j.celrep.2016.04.07810.1016/j.celrep.2016.04.078 ↗
18. 10.1172/jci.insight.13665310.1172/jci.insight.136653 ↗
19. 10.3390/vaccines1301007610.3390/vaccines13010076 ↗
20. 10.1126/sciadv.aau676910.1126/sciadv.aau6769 ↗
21. 10.1016/j.coi.2020.01.00710.1016/j.coi.2020.01.007 ↗
22. 10.1038/s41590-022-01163-910.1038/s41590-022-01163-9 ↗
23. 10.1056/NEJMc221623310.1056/NEJMc2216233 ↗